Biliary Tract Cancer near Saint Petersburg, FL

Biography: Dr. Andreas Karachristos, MD is an Oncology Specialist who practices in Tampa, FL. He is 57 years old and has been practicing for 33 years. Dr. Andreas Karachristos, MD is affiliated with Tampa General Hospital and Tampa General Hospital.

Care Philosophy: Dr Haider is an Associate Member in the Department of Gastrointestinal Oncology at Moffitt Cancer Center and an Associate Professorof Oncologic Sciences at University of South Florida. Dr Haider received her Bachelor of Science as well as her Medical Degree at the University of Florida in Gainesville, FL. She completed an internship and residency in Internal Medicine at the University of Southern California in Los Angeles, CA followed by Hematology and Medical Oncology Fellowship at Moffitt Cancer Center - University of South Florida in Tampa, FL. Dr Haider's clinical practice is focused on neuroendocrine tumor (NET) oncology. As a member of the Endocrine Program Multidisciplinary team, she also treats paraganglioma and pheochromocytoma.

Care Philosophy: Dr Al-Jumayli is certified in Hematology, Medical Oncology, and Geriatric Medicine. He received his medical degree from Al-Mustansiriyah University College of Medicine, Iraq. He completed an Internal Medicine Residency at Capital Health Regional Medical Center in New Jersey, followed by a Geriatric Fellowship at Baylor College of Medicine, Texas. He completed a Hematology-Oncology Fellowship at the University of Kansas. Dr Al-Jumayli's clinical focus is on the treatment of cancer in senior adults, particularly gastrointestinal Oncolgoy (GI) cancer with providing a personalized cancer care based on patients' functional status, general health, values, and goals.

Care Philosophy: Dr Iman Imanirad is an Assistant Member at Moffitt Cancer Center. He is also a Professor of Oncology at the University of South Florida College of Medicine. Dr Imanirad received his medical degree from Saba University School of Medicine and completed his residency at the University of Florida where he also completed three years of hematology oncology fellowship. After completing his fellowship, he worked as a medical Oncologist and hematologist at Tallahassee Memorial Hospital to fulfill the requirements for a J1 visa. During his fellowship, Dr Imanirad was the recipient of several awards such as Most Outstanding Fellow Award and Fellow of the Year Award. He was also awarded the Moffitt High Performer Award in 2019.

Care Philosophy: Dr Tiago Biachi de Castria is an Associate Member in the Department of Gastrointestinal Oncology at Moffitt Cancer Center. Dr Biachi de Castria received his MD degree from Universidade Federal de Civ™ncias da Sav?de de Porto Alegre, Brazil. He also obtained a Doctorate degree in Internal Medicine and Therapeutics from Svo Paulo Federal University. He completed his Residency in Internal Medicine at Svo Paulo Federal University and his Clinical Oncology Fellowship at the Svo Paulo University - Svo Paulo Cancer Institute. Dr Biachi de Castria was an attending in the Gastrointestinal Oncology Service at the Svo Paulo Cancer Institute and Sv?rio-Libanv™s Hospital.

Biography: Dr. Noman Ashraf, MD is an Oncology Specialist who practices in Tampa, FL. He is 45 years old. Dr. Noman Ashraf, MD is affiliated with Tampa General Hospital and Tampa General Hospital.

Care Philosophy: Dr Christine Sam is an Assistant Member in the Department of Individualized Cancer Management/Senior Adult Oncology Program. Dr Sam received her medical degree from Michigan State University College of Human Medicine in East Lansing. She completed an Internal Medicine Residency at University of Michigan Health Systems in Ann Arbor. She completed her Hematology and Medical Oncology Fellowship at Moffitt Cancer Center/University of South Florida Morsani College of Medicine in Tampa. Dr Sam's primary clinical interest is the treatment of cancer in older patients and developing care plans tailored to their individual needs. Her focus is the treatment of breast, gastrointestinal, and genitourinary malignancies.

Care Philosophy: Dr Richard Levine is the Medical Director at Moffitt International Plaza (MIP). Dr Levine received his MD and MS in Pharmacology from Indiana University. He completed an internal medicine residency at the University of Cincinnati Medical Center and a medical oncology fellowship at the National Cancer Institute, Medical Branch. He joins Moffitt from Space Coast Cancer Center, where he served as President and founder. Dr Levine was the Chairman of the Cancer Committee and Tumor Board of Parrish Medical Center and Cape Canaveral Hospital for 25 years.

Care Philosophy: Dr Shafique earned his Medical Degree from the University of Virginia School of Medicine and completed an Internal Medicine residency at Duke University Medical Center and a subsequent Hematology and Medical Oncology fellowship at the University of South Florida/Moffitt Cancer Center. Although Dr Shafique devotes most of his time to treating patients with lung cancer, he also sees patients with a broad spectrum of diagnoses as part of early-phase clinical trials. Additionally, he manages medical oncology treatments for patients with Gynecologic malignancies.

Care Philosophy: Dr Richard Kim is a Service Chief of Medical Gastrointestinal Oncology and Senior Member in the Gastrointestinal Oncology Department at Moffitt Cancer Center. He is a Professor of Oncology at the University of South Florida College of Medicine. Dr Kim received his medical degree from the University of Miami School of Medicine and completed a residency in internal medicine at the University of Illinois at Chicago. He pursued a postdoctoral fellowship in hematology and medical oncology at Yale University Comprehensive Cancer Center in New Haven, CT.

Care Philosophy: Dr Extermann is Program Leader in the Senior Adult Oncology Program at Moffitt Cancer Center. Dr Martine Extermann is also a Professor of Oncology and Medicine at the University of South Florida. She earned her medical degree and a PhD at the University of Geneva, Switzerland. She has a Swiss Board Certification in Internal Medicine, specializing in Hematology-Oncology. She also holds ABIM certifications in Internal Medicine and Medical Oncology. She has worked at Moffitt since 1994 and has been a faculty member since 1997. Her clinical activity and research focus on cancer in older patients.

Care Philosophy: Dr Daniel Anaya is a Senior Member, Chief of GI Surgery and Head of Hepatobiliary Section in the Department of Gastrointestinal Oncology, at Moffitt Cancer Center. Dr Anaya is a fellowship trained Surgical Oncologist with a particular focus on the surgical treatment of patients with liver malignancies (primary and metastatic) and neuroendocrine tumors. His academic interest focus on improving the quality of cancer care and implementing models to improve the delivery of care for patients with complex cancers. He is an expert in developing academic programs that facilitate delivery of the highest quality of care, while also provide a framework to support research and innovation in the field of cancer and surgery.

Care Philosophy: Dr Jason W Denbo is an Assistant Member in the Department of Gastrointestinal Oncology. Dr Denbo earned his MD degree at Indiana University School of Medicine and completed a General Surgery Residency at the University of Tennessee Health Science Center and a Research Fellowship at St. Jude Children's Research Hospital in Memphis, TN. Dr Denbo received fellowship training in both Complex General Surgical Oncology and Advanced Hepatopancreatobiliary Surgery at MD Anderson Cancer Center. Prior to his recruitment to Moffitt, Dr Denbo served as an Assistant Professor in the Department of Surgery at the University of Minnesota.

Care Philosophy: Dr Tanvetyanon is a medical oncologist with expertise in lung cancer, mesothelioma and thymic carcinoma. Services offered include a wide array of clinical trials, immunotherapy programs, and hyperthermic intraperitoneal chemotherapy (HIPEC) for malignant mesothelioma. In addition, Dr Tanvetyanon is experienced in managing abnormal findings from lung cancer screening. Dr Tanvetyanon is a health outcomes researcher as well as an epidemiologist. To date, he has published over 50 peer-review articles in medical journals including Journal of Clinical Oncology, Annals of Oncology, Head & Neck and Journal of Thoracic Oncology.

Care Philosophy: Dr Jonathan Strosberg is a professor at Moffitt Cancer Center specializing in the management of neuroendocrine malignancies. He is a graduate of Harvard University and Cornell University Medical College and completed his residency and fellowship training programs at Georgetown University Hospital and Moffitt Cancer Center. He leads Moffitt's Neuroendocrine Tumor Division and Department of Gastrointestinal Oncology Research Program. Dr Strosberg has published over 150 articles on the diagnosis and management of neuroendocrine malignancies, with first-author publications in the New England Journal of Medicine, Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research and other major journals.

Care Philosophy: Dr. Naraev believes in compassionate, personalized care that is focused on his patients, their hopes, needs and quality of life.

Care Philosophy: Dr. Iswanto Sucandy is a highly experienced board-certified surgeon with dual fellowship training in Hepatobiliary and Pancreatic Surgery, as well as Advanced Gastrointestinal Minimally Invasive Surgery. He primarily specializes in minimally invasive and robotic surgery for disorders of the liver.

Care Philosophy: Dr Eroglu is a medical oncologist in the Department of Cutaneous Oncology at Moffitt Cancer Center and an assistant professor in the Department of Oncologic Sciences at the University of South Florida Morsani College of Medicine. Her clinical focus is on treating patients with advanced melanoma and other skin cancers, including basal cell carcinoma and Merkel cell carcinoma, and participating in clinical trials.Dr Eroglu's research interests are translational and clinical research in targeted therapies and combination immunotherapeutics for melanoma and other skin cancers, along with development of personalized treatment strategies and biomarkers for patients with melanoma.